
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
SARS-CoV-2 evolution in an immunocompromised host reveals shared neutralization escape mechanisms
Sarah A. Clark, Lars E. Clark, Junhua Pan, et al.
Cell (2021) Vol. 184, Iss. 10, pp. 2605-2617.e18
Open Access | Times Cited: 177
Sarah A. Clark, Lars E. Clark, Junhua Pan, et al.
Cell (2021) Vol. 184, Iss. 10, pp. 2605-2617.e18
Open Access | Times Cited: 177
Showing 1-25 of 177 citing articles:
SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
Wanwisa Dejnirattisai, Jiandong Huo, Daming Zhou, et al.
Cell (2022) Vol. 185, Iss. 3, pp. 467-484.e15
Open Access | Times Cited: 921
Wanwisa Dejnirattisai, Jiandong Huo, Daming Zhou, et al.
Cell (2022) Vol. 185, Iss. 3, pp. 467-484.e15
Open Access | Times Cited: 921
Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms
Amy D. Proal, Michael B. VanElzakker
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 729
Amy D. Proal, Michael B. VanElzakker
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 729
The evolution of SARS-CoV-2
Peter V. Markov, Mahan Ghafari, Martin Beer, et al.
Nature Reviews Microbiology (2023) Vol. 21, Iss. 6, pp. 361-379
Open Access | Times Cited: 724
Peter V. Markov, Mahan Ghafari, Martin Beer, et al.
Nature Reviews Microbiology (2023) Vol. 21, Iss. 6, pp. 361-379
Open Access | Times Cited: 724
Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum
Aekkachai Tuekprakhon, Rungtiwa Nutalai, Aiste Dijokaite-Guraliuc, et al.
Cell (2022) Vol. 185, Iss. 14, pp. 2422-2433.e13
Open Access | Times Cited: 668
Aekkachai Tuekprakhon, Rungtiwa Nutalai, Aiste Dijokaite-Guraliuc, et al.
Cell (2022) Vol. 185, Iss. 14, pp. 2422-2433.e13
Open Access | Times Cited: 668
Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2
Pengcheng Han, Linjie Li, Sheng Liu, et al.
Cell (2022) Vol. 185, Iss. 4, pp. 630-640.e10
Open Access | Times Cited: 449
Pengcheng Han, Linjie Li, Sheng Liu, et al.
Cell (2022) Vol. 185, Iss. 4, pp. 630-640.e10
Open Access | Times Cited: 449
Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron
Zhen Cui, Pan Liu, Nan Wang, et al.
Cell (2022) Vol. 185, Iss. 5, pp. 860-871.e13
Open Access | Times Cited: 379
Zhen Cui, Pan Liu, Nan Wang, et al.
Cell (2022) Vol. 185, Iss. 5, pp. 860-871.e13
Open Access | Times Cited: 379
Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant by Sera From BNT162b2 or CoronaVac Vaccine Recipients
Lu Lu, Bobo Wing-Yee Mok, Lin Lei Chen, et al.
Clinical Infectious Diseases (2021) Vol. 75, Iss. 1, pp. e822-e826
Open Access | Times Cited: 373
Lu Lu, Bobo Wing-Yee Mok, Lin Lei Chen, et al.
Clinical Infectious Diseases (2021) Vol. 75, Iss. 1, pp. e822-e826
Open Access | Times Cited: 373
Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants
Meng Yuan, Deli Huang, Chang‐Chun D. Lee, et al.
Science (2021) Vol. 373, Iss. 6556, pp. 818-823
Open Access | Times Cited: 362
Meng Yuan, Deli Huang, Chang‐Chun D. Lee, et al.
Science (2021) Vol. 373, Iss. 6556, pp. 818-823
Open Access | Times Cited: 362
De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: a case report
Shiv Gandhi, Jon Klein, Alexander J. Robertson, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 238
Shiv Gandhi, Jon Klein, Alexander J. Robertson, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 238
Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection
Yu‐Chyi Hwang, Ruei‐Min Lu, Shih-Chieh Su, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 194
Yu‐Chyi Hwang, Ruei‐Min Lu, Shih-Chieh Su, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 194
SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape
Sandile Cele, Farina Karim, Gila Lustig, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 2, pp. 154-162.e5
Open Access | Times Cited: 193
Sandile Cele, Farina Karim, Gila Lustig, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 2, pp. 154-162.e5
Open Access | Times Cited: 193
Tracking SARS-CoV-2 Omicron diverse spike gene mutations identifies multiple inter-variant recombination events
Junxian Ou, Wendong Lan, Xiaowei Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 187
Junxian Ou, Wendong Lan, Xiaowei Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 187
Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variants
Saya Moriyama, Yu Adachi, Takashi Sato, et al.
Immunity (2021) Vol. 54, Iss. 8, pp. 1841-1852.e4
Open Access | Times Cited: 138
Saya Moriyama, Yu Adachi, Takashi Sato, et al.
Immunity (2021) Vol. 54, Iss. 8, pp. 1841-1852.e4
Open Access | Times Cited: 138
The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK
Verity Hill, Louis du Plessis, Thomas P. Peacock, et al.
Virus Evolution (2022) Vol. 8, Iss. 2
Open Access | Times Cited: 127
Verity Hill, Louis du Plessis, Thomas P. Peacock, et al.
Virus Evolution (2022) Vol. 8, Iss. 2
Open Access | Times Cited: 127
Neutralization of SARS-CoV-2 Omicron variant by sera from BNT162b2 or Coronavac vaccine recipients
Lu Lu, Bobo Wing-Yee Mok, Lin‐Lei Chen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 123
Lu Lu, Bobo Wing-Yee Mok, Lin‐Lei Chen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 123
Concerns about SARS-CoV-2 evolution should not hold back efforts to expand vaccination
Sarah Cobey, Daniel B. Larremore, Yonatan H. Grad, et al.
Nature reviews. Immunology (2021) Vol. 21, Iss. 5, pp. 330-335
Open Access | Times Cited: 122
Sarah Cobey, Daniel B. Larremore, Yonatan H. Grad, et al.
Nature reviews. Immunology (2021) Vol. 21, Iss. 5, pp. 330-335
Open Access | Times Cited: 122
Structural and antigenic variations in the spike protein of emerging SARS-CoV-2 variants
Anshumali Mittal, Arun Khattri, Vikash Verma
PLoS Pathogens (2022) Vol. 18, Iss. 2, pp. e1010260-e1010260
Open Access | Times Cited: 115
Anshumali Mittal, Arun Khattri, Vikash Verma
PLoS Pathogens (2022) Vol. 18, Iss. 2, pp. e1010260-e1010260
Open Access | Times Cited: 115
Delta Variants of SARS-CoV-2 Cause Significantly Increased Vaccine Breakthrough COVID-19 Cases in Houston, Texas
Paul A. Christensen, Randall J. Olsen, Sheng Long, et al.
American Journal Of Pathology (2021) Vol. 192, Iss. 2, pp. 320-331
Open Access | Times Cited: 110
Paul A. Christensen, Randall J. Olsen, Sheng Long, et al.
American Journal Of Pathology (2021) Vol. 192, Iss. 2, pp. 320-331
Open Access | Times Cited: 110
Recurrent SARS-CoV-2 mutations in immunodeficient patients
Samuel Wilkinson, Alex Richter, Anna Casey, et al.
Virus Evolution (2022) Vol. 8, Iss. 2
Open Access | Times Cited: 103
Samuel Wilkinson, Alex Richter, Anna Casey, et al.
Virus Evolution (2022) Vol. 8, Iss. 2
Open Access | Times Cited: 103
Deciphering the language of antibodies using self-supervised learning
Jinwoo Leem, L. Mitchell, James H. R. Farmery, et al.
Patterns (2022) Vol. 3, Iss. 7, pp. 100513-100513
Open Access | Times Cited: 97
Jinwoo Leem, L. Mitchell, James H. R. Farmery, et al.
Patterns (2022) Vol. 3, Iss. 7, pp. 100513-100513
Open Access | Times Cited: 97
Cumulative SARS-CoV-2 mutations and corresponding changes in immunity in an immunocompromised patient indicate viral evolution within the host
Sissy Therese Sonnleitner, Martina Prelog, Stefanie Sonnleitner, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 94
Sissy Therese Sonnleitner, Martina Prelog, Stefanie Sonnleitner, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 94
A large-scale systematic survey reveals recurring molecular features of public antibody responses to SARS-CoV-2
Yiquan Wang, Meng Yuan, Huibin Lv, et al.
Immunity (2022) Vol. 55, Iss. 6, pp. 1105-1117.e4
Open Access | Times Cited: 85
Yiquan Wang, Meng Yuan, Huibin Lv, et al.
Immunity (2022) Vol. 55, Iss. 6, pp. 1105-1117.e4
Open Access | Times Cited: 85
Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domain
Katherine Nabel Smith, Sarah A. Clark, Sundaresh Shankar, et al.
Science (2022) Vol. 375, Iss. 6578
Open Access | Times Cited: 75
Katherine Nabel Smith, Sarah A. Clark, Sundaresh Shankar, et al.
Science (2022) Vol. 375, Iss. 6578
Open Access | Times Cited: 75
SARS-CoV-2 Variants of Concern and Variants of Interest Receptor Binding Domain Mutations and Virus Infectivity
Haolin Liu, Pengcheng Wei, John W. Kappler, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 70
Haolin Liu, Pengcheng Wei, John W. Kappler, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 70
Germline-encoded amino acid–binding motifs drive immunodominant public antibody responses
Ellen Shrock, Richard T. Timms, Tomasz Kula, et al.
Science (2023) Vol. 380, Iss. 6640
Open Access | Times Cited: 55
Ellen Shrock, Richard T. Timms, Tomasz Kula, et al.
Science (2023) Vol. 380, Iss. 6640
Open Access | Times Cited: 55